Peter Selin, born in 1973, is the CEO at Kancera and also operationally responsible for finance, business development and investor relations. Peter has 20 years of international experience from the biotech and pharmaceutical industry and has extensive experience and expertise within commercialization of specialty care products, business development, strategy and corporate finance. Peter has previously held senior positions within both business development and operations, e.g. as Chief Business Officer at Vivesto AB, Vice President Business Operations at Inceptua Group and Vice President Corporate Development at Sobi. Prior to joining the pharma industry he worked as management consultant at EY. Peter holds a Bachelor of Science degree in Business Administration from Uppsala University. Peter was appointed to CEO in 2023.